The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Padigel, U. M.
Right arrow Articles by Farrell, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Padigel, U. M.
Right arrow Articles by Farrell, J. P.
The Journal of Immunology, 2003, 171: 3705-3710.
Copyright © 2003 by The American Association of Immunologists

The Role of Interleukin-10 in Susceptibility of BALB/c Mice to Infection with Leishmania mexicana and Leishmania amazonensis1

Udaikumar M. Padigel*, James Alexander{dagger} and Jay P. Farrell2,*

* Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104; and {dagger} Department of Immunology, University of Strathclyde, Strathclyde Institute for Biomedical Sciences, Glasgow, United Kingdom

Recent studies have demonstrated the critical role of IL-10 in susceptibility to cutaneous and visceral leishmaniasis caused by Leishmania major and Leishmania donovani, respectively. To determine whether IL-10 also plays a similar role in the susceptibility and pathogenesis of cutaneous leishmaniasis caused by the New World species, L. mexicana and L. amazonensis, we analyzed their course of infection in IL-10-deficient BALB/c mice and their wild-type counterparts. Although IL-10-deficient mice infected with either L. mexicana or L. amazonensis failed to control the lesion progression, we did observe consistently lower levels of infection in IL-10-/- mice compared with wild-type BALB/c mice. We also observed increased IFN-{gamma} and NO production and higher levels for IL-12p40 and IL-12R{beta}2 mRNA in cells from IL-10-/- mice compared with cells from BALB/c mice. The mRNA levels for IL-4, which increased significantly in both IL-10-/- and BALB/c mice, were comparable. When treated with anti-IL-4 mAb, IL-10-/- mice resolved the infection more effectively and had significantly fewer parasites in their lesions compared with similarly treated BALB/c mice. These findings suggest that IL-10, although not the dominant mediator of susceptibility of BALB/c mice to infection with L. mexicana and L. amazonensis, does play a significant role in regulating the development of a protective Th1-type response. However, effective resolution of infection with these New World parasites requires neutralization of both IL-4 and IL-10.




This article has been cited by other articles:


Home page
 Infect. Immun.Home page
A. Maurer-Cecchini, S. Decuypere, F. Chappuis, C. Alexandrenne, S. De Doncker, M. Boelaert, J.-C. Dujardin, L. Loutan, J.-M. Dayer, G. Tulliano, et al.
Immunological Determinants of Clinical Outcome in Peruvian Patients with Tegumentary Leishmaniasis Treated with Pentavalent Antimonials
Infect. Immun., May 1, 2009; 77(5): 2022 - 2029.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. M. Whitaker, M. Colmenares, K. G. Pestana, and D. McMahon-Pratt
Leishmania pifanoi Proteoglycolipid Complex P8 Induces Macrophage Cytokine Production through Toll-Like Receptor 4
Infect. Immun., May 1, 2008; 76(5): 2149 - 2156.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
H. Nagase, K. M. Jones, C. F. Anderson, and N. Noben-Trauth
Despite Increased CD4+Foxp3+ Cells within the Infection Site, BALB/c IL-4 Receptor-Deficient Mice Reveal CD4+Foxp3-Negative T Cells as a Source of IL-10 in Leishmania major Susceptibility
J. Immunol., August 15, 2007; 179(4): 2435 - 2444.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Roque, C. Nobrega, R. Appelberg, and M. Correia-Neves
IL-10 Underlies Distinct Susceptibility of BALB/c and C57BL/6 Mice to Mycobacterium avium Infection and Influences Efficacy of Antibiotic Therapy
J. Immunol., June 15, 2007; 178(12): 8028 - 8035.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
P. A. Barroso, J. D. Marco, M. Calvopina, H. Kato, M. Korenaga, and Y. Hashiguchi
A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate
J. Antimicrob. Chemother., June 1, 2007; 59(6): 1123 - 1129.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z. Yang, D. M. Mosser, and X. Zhang
Activation of the MAPK, ERK, following Leishmania amazonensis Infection of Macrophages
J. Immunol., January 15, 2007; 178(2): 1077 - 1085.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
X. Sun, H. P. Jones, L. M. Hodge, and J. W. Simecka
Cytokine and Chemokine Transcription Profile during Mycoplasma pulmonis Infection in Susceptible and Resistant Strains of Mice: Macrophage Inflammatory Protein 1{beta} (CCL4) and Monocyte Chemoattractant Protein 2 (CCL8) and Accumulation of CCR5+ Th Cells.
Infect. Immun., October 1, 2006; 74(10): 5943 - 5954.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Bodas, N. Jain, A. Awasthi, S. Martin, R. K. Penke Loka, D. Dandekar, D. Mitra, and B. Saha
Inhibition of IL-2 Induced IL-10 Production as a Principle of Phase-Specific Immunotherapy
J. Immunol., October 1, 2006; 177(7): 4636 - 4643.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. H. Serezani, J. H. Perrela, M. Russo, M. Peters-Golden, and S. Jancar
Leukotrienes Are Essential for the Control of Leishmania amazonensis Infection and Contribute to Strain Variation in Susceptibility.
J. Immunol., September 1, 2006; 177(5): 3201 - 3208.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
M. D. Woolard, D. Hudig, L. Tabor, J. A. Ivey, and J. W. Simecka
NK Cells in Gamma-Interferon-Deficient Mice Suppress Lung Innate Immunity against Mycoplasma spp.
Infect. Immun., October 1, 2005; 73(10): 6742 - 6751.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
B. Dondji, E. Perez-Jimenez, K. Goldsmith-Pestana, M. Esteban, and D. McMahon-Pratt
Heterologous Prime-Boost Vaccination with the LACK Antigen Protects against Murine Visceral Leishmaniasis
Infect. Immun., August 1, 2005; 73(8): 5286 - 5289.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
U. M. Padigel and J. P. Farrell
Control of Infection with Leishmania major in Susceptible BALB/c Mice Lacking the Common {gamma}-Chain for FcR Is Associated with Reduced Production of IL-10 and TGF-{beta} by Parasitized Cells
J. Immunol., May 15, 2005; 174(10): 6340 - 6345.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
L. U. Buxbaum and P. Scott
Interleukin 10- and Fc{gamma} Receptor-Deficient Mice Resolve Leishmania mexicana Lesions
Infect. Immun., April 1, 2005; 73(4): 2101 - 2108.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. F. Anderson, S. Mendez, and D. L. Sacks
Nonhealing Infection despite Th1 Polarization Produced by a Strain of Leishmania major in C57BL/6 Mice
J. Immunol., March 1, 2005; 174(5): 2934 - 2941.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
Y. VANLOUBBEECK and D. E. JONES
PROTECTION OF C3HEB/FEJ MICE AGAINST LEISHMANIA AMAZONENSIS CHALLENGE AFTER PREVIOUS LEISHMANIA MAJOR INFECTION
Am J Trop Med Hyg, October 1, 2004; 71(4): 407 - 411.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.